[HTML][HTML] Evaluation of a genetic risk score computed using human chromosomal-scale length variation to predict breast cancer

C Ko, JP Brody - Human genomics, 2023 - Springer
Introduction The ability to accurately predict whether a woman will develop breast cancer later
in her life, should reduce the number of breast cancer deaths. Different predictive models …

[HTML][HTML] A genetic risk score for glioblastoma multiforme based on copy number variations

C Ko, JP Brody - Cancer treatment and research communications, 2021 - Elsevier
Glioblastoma multiforme is the most common form of brain cancer. Several lines of evidence
suggest that glioblastoma multiforme has a genetic basis. A genetic test that could identify …

A Genetic Risk Score using human chromosomal-scale length variation can predict breast cancer

C Ko, JP Brody - 2022 - researchsquare.com
Methods. We built machine learning models to differentiate between women who had breast
cancer and women who did not based on their CSLV characterization. We applied this …

[BOOK][B] Cancer Risk Determination through Chromosomal Scale Length Variations of Germline DNA

CS Ko - 2023 - search.proquest.com
Cancer is a complex disease with significant genetic components. Previous efforts to uncover
the genetic basis of carcinogenesis tend to focus on linear combinations of single genetic …

Single Tube Molecular Profiling of ALL Samples Reveals Integrated Molecular Signature and Highlights Gene Regulatory Networks

L Zelinger, S Koo, F Alarcon, C Ko, BB Thomas… - Blood, 2022 - ashpublications.org
Background: Over 20 acute lymphoblastic leukemia (ALL) subtypes are defined by
molecular signature, which is historically mainly dependent on genomic rearrangements (…

Abstract PR-09: Genetic risk scores for breast cancer based on machine learning analysis of chromosomal-scale length variation

C Ko, C Toh, JP Brody - Clinical Cancer Research, 2021 - AACR
Inherited factors are thought to be responsible for a substantial fraction of breast cancers,
but only a small fraction of breast cancers are caused by mutations to known genes, like …

Single-tube NGS profiling allows identification of molecular signature in ALL patients

L Zelinger, S Koo, C Ko, F Alarcon, KB Thomas… - Cancer Research, 2023 - AACR
Background: Acute lymphoblastic leukemia (ALL) can be classified to subtypes by molecular
signatures correlating to prognosis and treatment regimen, making accurate molecular …

[PDF][PDF] Genetic risk scores from structural variation predict life-time individual cancer risk

C Toh, C Ko, JP Brody - Sarcoma, 2020 - brodylab.eng.uci.edu
Results We tested this objective using data compiled by The Cancer Genome Atlas (TCGA)
project and the UK Biobank. TCGA data consisted of information on DNA chromosome scale …

[HTML][HTML] P090: NGS assay for simultaneous screening of DNA and RNA provides a comprehensive solution guiding clinical management of ALL patients

L Zelinger, C Ko, F Alarcon, S Koo, K Thomas… - Genetics in Medicine …, 2023 - gimopen.org
Methods Bone marrow (BM) and peripheral blood (PB) from ALL patients, healthy donors,
synthetic controls and cell lines with known fusions were used to establish sensitivity, …

NCI Cancer Research Data Commons: Cloud-based Analytical Resources

D Pot, Z Worman, A Baumann, S Pathak, R Beck… - Cancer Research, 2024 - AACR
The NCI’s Cloud Resources (CRs) are the analytical components of the Cancer Research
Data Commons (CRDC) ecosystem. This review describes how the three CRs (Broad Institute …